Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856602) titled 'Safety and Preliminary Efficacy of Adipose-Derived Stem Cell Secretome in Frailty (VinVital)' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Vinmec Research Institute of Stem Cell and Gene Technology
Condition:
Frailty Syndrome
Aging
Intervention:
Biological: VinVital
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: October 1, 2026
Target Sample Size: 20
To know more, visit https://clinicaltrials.gov/study/NCT07856602
Published by HT Di...